CY1110348T1 - Φαρμακευτικη μορφη για ληψη απο του στοματος με dienogest και αιθινυλ-οιστραδιολη για αντισυλληψη - Google Patents
Φαρμακευτικη μορφη για ληψη απο του στοματος με dienogest και αιθινυλ-οιστραδιολη για αντισυλληψηInfo
- Publication number
- CY1110348T1 CY1110348T1 CY20091100928T CY091100928T CY1110348T1 CY 1110348 T1 CY1110348 T1 CY 1110348T1 CY 20091100928 T CY20091100928 T CY 20091100928T CY 091100928 T CY091100928 T CY 091100928T CY 1110348 T1 CY1110348 T1 CY 1110348T1
- Authority
- CY
- Cyprus
- Prior art keywords
- dienogest
- ethinyl
- ostradiol
- contract
- pharmaceutical form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Μια φαρμακευτική μορφή για λήψη από του στόματος για αντισύλληψη περιέχει ως ένα δραστικό συστατικό 17α-κυανομεθυλο-17-β-υδροξυοιστρα-4,9-διεν-3-ονη (Dienogest) σε μια ημερήσια δοσολογία ίση με ή μικρότερη από 2,0 mg και ως άλλο δραστικό συστατικό 17α-αιθινυλ-οιστραδιόλη (αιθινυλ-οιστραδιόλη) σε μια ημερήσια δοσολογία μικρότερη από 0,03mg μαζί με έναν ή περισσότερους φαρμακευτικά ανεκτούς φορείς. Η δραστική ουσία Dienogest περιέχεται σε κρυσταλλική μορφή με ένα μέσο μέγεθος σωματιδίων από 25 έως 70 μm. Η δραστική ουσία αιθινυλ-οιστραδιόλη εισάγεται σε μικροκονιοποιημένη μορφή ή ως αιθανολικό διάλυμα κατά τη διάρκεια της κοκκοποίησης.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06016694A EP1886694B1 (de) | 2006-08-10 | 2006-08-10 | Perorale Arzneiform mit Dienogest und Ethinylestradiol zur Kontrazeption |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110348T1 true CY1110348T1 (el) | 2015-04-29 |
Family
ID=37561777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091100928T CY1110348T1 (el) | 2006-08-10 | 2009-09-03 | Φαρμακευτικη μορφη για ληψη απο του στοματος με dienogest και αιθινυλ-οιστραδιολη για αντισυλληψη |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1886694B1 (el) |
AR (1) | AR062323A1 (el) |
AT (1) | ATE432714T1 (el) |
CL (1) | CL2007002323A1 (el) |
CY (1) | CY1110348T1 (el) |
DE (1) | DE502006003892D1 (el) |
DK (1) | DK1886694T3 (el) |
DO (1) | DOP2007000122A (el) |
ES (1) | ES2327665T3 (el) |
HR (1) | HRP20090438T1 (el) |
NO (1) | NO20091057L (el) |
PE (1) | PE20080541A1 (el) |
PL (1) | PL1886694T3 (el) |
PT (1) | PT1886694E (el) |
SI (1) | SI1886694T1 (el) |
TW (1) | TW200817012A (el) |
UY (1) | UY30530A1 (el) |
WO (1) | WO2008017331A2 (el) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010003711B4 (de) * | 2010-04-08 | 2015-04-09 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoffpartikel |
CN115487198B (zh) * | 2022-09-20 | 2024-01-02 | 华中药业股份有限公司 | 一种快溶出度的左炔诺孕酮制剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1216713A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
DE10218107A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
-
2006
- 2006-08-10 DE DE502006003892T patent/DE502006003892D1/de active Active
- 2006-08-10 SI SI200630376T patent/SI1886694T1/sl unknown
- 2006-08-10 DK DK06016694T patent/DK1886694T3/da active
- 2006-08-10 ES ES06016694T patent/ES2327665T3/es active Active
- 2006-08-10 PT PT06016694T patent/PT1886694E/pt unknown
- 2006-08-10 AT AT06016694T patent/ATE432714T1/de active
- 2006-08-10 PL PL06016694T patent/PL1886694T3/pl unknown
- 2006-08-10 EP EP06016694A patent/EP1886694B1/de active Active
-
2007
- 2007-04-26 WO PCT/EP2007/003662 patent/WO2008017331A2/de active Application Filing
- 2007-07-16 TW TW096125903A patent/TW200817012A/zh unknown
- 2007-08-07 UY UY30530A patent/UY30530A1/es unknown
- 2007-08-09 CL CL200702323A patent/CL2007002323A1/es unknown
- 2007-08-09 PE PE2007001064A patent/PE20080541A1/es not_active Application Discontinuation
- 2007-08-09 DO DO2007000122A patent/DOP2007000122A/es unknown
- 2007-08-10 AR ARP070103547A patent/AR062323A1/es not_active Application Discontinuation
-
2009
- 2009-03-09 NO NO20091057A patent/NO20091057L/no not_active Application Discontinuation
- 2009-08-13 HR HR20090438T patent/HRP20090438T1/xx unknown
- 2009-09-03 CY CY20091100928T patent/CY1110348T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL1886694T3 (pl) | 2009-11-30 |
PE20080541A1 (es) | 2008-07-10 |
NO20091057L (no) | 2009-03-09 |
ES2327665T3 (es) | 2009-11-02 |
HRP20090438T1 (en) | 2009-09-30 |
DK1886694T3 (da) | 2009-09-28 |
DOP2007000122A (es) | 2008-02-15 |
UY30530A1 (es) | 2008-03-31 |
TW200817012A (en) | 2008-04-16 |
CL2007002323A1 (es) | 2008-02-15 |
ATE432714T1 (de) | 2009-06-15 |
DE502006003892D1 (de) | 2009-07-16 |
EP1886694A1 (de) | 2008-02-13 |
AR062323A1 (es) | 2008-10-29 |
EP1886694B1 (de) | 2009-06-03 |
SI1886694T1 (sl) | 2009-10-31 |
WO2008017331A2 (de) | 2008-02-14 |
PT1886694E (pt) | 2009-08-17 |
WO2008017331A3 (de) | 2009-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP36008A (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
TR200003788A2 (tr) | Yavaş salımlı oral dozaj bileşim. | |
BG66095B1 (bg) | Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат | |
JP2007535519A5 (el) | ||
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
RU2009102443A (ru) | Фармацевтический препарат для контрацепции и для предотвращения риска врожденных пороков развития | |
NO327588B1 (no) | Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel | |
CY1110348T1 (el) | Φαρμακευτικη μορφη για ληψη απο του στοματος με dienogest και αιθινυλ-οιστραδιολη για αντισυλληψη | |
EA200701389A1 (ru) | Твёрдая пероральная лекарственная форма для контрацепции | |
JP2011507853A5 (el) | ||
DOP2006000035A (es) | Preparación farmaceútica para la anticoncepción oral | |
TW200731977A (en) | Use of estradiol valerate in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception | |
TW200638951A (en) | Solid oral pharmaceutical form for contraception | |
UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral | |
CY1112775T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος | |
TH80558B (th) | รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด | |
TH80558A (th) | รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด | |
BR0311209A (pt) | Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete | |
TH148141A (th) | การใช้เอสตราไดออลวาเลอเรตหรือเอสตราไดออลร่วมกับไดอีโนเจสต์สำหรับการรักษาโดยให้ทางปากในการตกเลือดในมดลูกแบบที่ทำงานผิดปกติ ร่วมกับยาคุมกำเนิดสำหรับให้ทางปาก | |
TH80557B (th) | ผลิตภัณฑ์ทางเภสัชกรรมสำหรับการคุมกำเนิดทางช่องปาก | |
TH54054B (th) | สารผสมทางเภสัชกรรมสำหรับใช้เป็นยาคุมกำเนิด | |
CR9240A (es) | Forma farmacologica peroral solida para la anticoncepcion |